Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 154Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 17GILEAD SCIENCES INC

02 5MSD MERCK CO

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Battery Seminar
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 8633219

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203100

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2030-04-30

blank

02

arrow
Battery Seminar
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 7635704

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203100

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2026-10-26

blank

03

arrow
Battery Seminar
Not Confirmed

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 8841310

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202123

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2025-12-09

blank

04

arrow
Battery Seminar
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 8148374

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203100

Patent Use Code : U-1279

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2029-09-03

blank

05

arrow
Battery Seminar
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 7176220

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203100

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2026-08-27

blank

06

arrow
Battery Seminar
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 9891239

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203100

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2029-09-03

blank

07

arrow
Battery Seminar
Not Confirmed

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 7125879

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202123

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2025-04-21

blank

08

arrow
Battery Seminar
Not Confirmed

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 10857102

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202123

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-14

blank

09

arrow
Battery Seminar
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 10039718

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203100

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-06

blank

10

arrow
Battery Seminar
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 8981103

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203100

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-10-26

blank